Pop quiz! Who's dumber? Those courting health risks at the Sturgis motorcycle rally or the authors of the "study" making the rounds on the thousands of infections they created? OK, it's a trick question, because both groups have some explaining to do.

The beginner's mind, a video of Tesla production (can you see what is missing?), a video that will put a smile on your face and bring back the joy of opening a present when you were a tween, how will the rise in remote work change our lives, and finally, a question of expertise.

It is difficult to overstate the potential damage that an ineffective or unsafe coronavirus vaccine could inflict on confidence in public health institutions. Conspiracy theories already abound and would multiply further.

Are there geographical differences in the spread of COVID-19? Does a region's "culture" contribute to the pandemic or simply the population density? Good questions. Let's take a look.

It's time for the Centers for Disease Control and Prevention to withdraw this page to correct its many errors and distortions.  A principal author of the 2016 CDC Guidelines on the prescription of opioids to adults with chronic pain is responsible for many of these errors. Richard Lawhern (pictured) addressed these mistakes in this open letter.

Skin cancers are among the most common tumors; after all, we're all held together by our skin. The improvements in 3D-ultrasounds provide a one-step measurement of a suspicious area's size, depth, margins, and tumor aggression. More importantly, it identifies the tumor invisible to the eye, a critical factor in skin cancer recurrence. 

I read a short article this week about the social history surrounding epidemics. Like much of history, it has eerie similarities to our current times. Is it a precautionary tale, or a random pattern we imbue with meaning as we try to connect the dots?

The University of Oxford, in collaboration with British pharmaceutical firm AstraZeneca, has produced a leading coronavirus vaccine candidate. However, the Phase 3 clinical trial was paused because one patient is thought to have developed a serious adverse reaction. What could it be?

Everyone knows that the elderly and those with co-morbidities are at greater risk for hospitalization and death from COVID-19. But are all co-morbidities the same? Do some conditions result in more or perhaps fewer hospitalizations and deaths? Let's take a look.

What happens when politics and science mix? Scary stuff. Dr. Henry Miller examines the considerable downside of releasing any COVID vaccine prior to the completion of Phase 3 trials. The founding director of the FDA's Office of Biotechnology, Dr. Miller argues that precise science, not the date of an election, is critical at this time.